Univercells Company
Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions, with innovative engineering able to decrease the needs for investments of over 75% and the cost of goods of up to 90%. Univercells' technologies, aimed at low cost manufacturing of antibodies/proteins/vaccines, is based on single-use technologies, and chaining of three manufacturing steps into simulated continuous mode : cell culture under perfusion, clarification and capture.
Technology:
Others
Industry:
Biotechnology, Health Care, Manufacturing, Science and Engineering
Headquarters:
Gosselies, Hainaut, Belgium
Founded Date:
2013-01-01
Employees Number:
11-50
Investors Number:
10
Total Funding:
$94.5M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership